No one wants to see a bunch of people be treated with something that causes an unexpected serious adverse reaction. Have to start slow and prove the safety.
- Forums
- ASX - By Stock
- PYC
- Ann: Initial Dosing Completed in Cohort 1 of RP11 MAD Study
PYC
pyc therapeutics limited
Add to My Watchlist
3.33%
!
$1.16

Ann: Initial Dosing Completed in Cohort 1 of RP11 MAD Study, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.16 |
Change
-0.040(3.33%) |
Mkt cap ! $676.5M |
Open | High | Low | Value | Volume |
$1.18 | $1.20 | $1.15 | $141.8K | 121.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10097 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 2870 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10097 | 1.160 |
2 | 16912 | 1.155 |
6 | 77654 | 1.150 |
3 | 7060 | 1.145 |
3 | 55269 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 2870 | 5 |
1.185 | 9888 | 4 |
1.190 | 1300 | 2 |
1.195 | 198 | 1 |
1.200 | 13215 | 3 |
Last trade - 15.36pm 18/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online